Headache and Migraine

The director of the Pediatric Headache Program at CHOP commented on the need to treat migraine early to avoid secondary effects and decrease the odds of long-term disability. [WATCH TIME: 3 minutes]

Years of mounting data has led the National Headache Foundation to release recommendations on how patients and clinicians come to the right decisions on migraine therapy.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 21, 2022.

Discussing the need to identify an effective first-line treatment, the director of the Pediatric Headache Program at CHOP further discussed treatment adherence in this patient population. [WATCH TIME: 5 minutes]

The director of the Pediatric Headache Program at CHOP commented on the available therapies for children with migraine, as well as future developments. [WATCH TIME: 4 minutes]

The director of the Pediatric Headache Program at CHOP broke down the treatment of pediatric migraine into 3 different pieces: lifestyle habits, acute treatment, and preventive therapies. [WATCH TIME: 5 minutes]

The director of the CHOP Pediatric Headache Program commented on the commonality of migraine in children and the need to improve diagnostic practices. [WATCH TIME: 4 minutes]

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending January 15, 2022. [WATCH TIME: 4 minutes]

Expert clinicians offer their insight on costs of Alzheimer drug development, a new agent for generalized myasthenia gravis, migraine in the emergency department, educational sleep medicine “boot camps”, AES 2021, and more.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 14, 2022.

A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Anne-Maree Kelly, MD, MClinEd, FACEM. [LISTEN TIME: 23 minutes]

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

The director of the Joseph Epstein Center for Emergency Medicine Research discussed whether years of experience causes variation in the way migraine is diagnosed and treated in an emergency department setting. [WATCH TIME: 2 minutes]

The noninvasive vagus nerve stimulation device showed results consistent with what had been previously observed in the literature, with a particular benefit observed for those who have migraine with aura.

Here's what is coming soon to NeurologyLive®.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 7, 2022.

A discussion on when a patient should be referred to a headache specialist for preventive migraine treatment.

Jessica Ailani, MD, details how the phase 3 ADVANCE trial will shape the research of future agents for preventive migraine treatment.

Anne-Maree Kelly, MD, director, Joseph Epstein Center for Emergency Medicine Research, detailed the complexities of presenting migraine in the emergency department and why consensus international/national guidelines tailorable to the capabilities of institutions is necessary.

The director of the Joseph Epstein Center for Emergency Medicine Research provided context on the types of research needed to further evaluate and improve diagnosis and management of headache in emergency departments. [WATCH TIME: 3 minutes]

Christina Szperka, MD, MSCE, the director of the Pediatric Headache Program at CHOP, offered her perspective on the challenges in conducting pediatric migraine trials and the advances made recently.

Here's what is coming soon to NeurologyLive®.

Amid a changing and evolving landscape for adult migraine care, Christina Szperka, MD, MSCE, director of the CHOP Pediatric Headache Program, offered insight into the standard experience in pediatric migraine care.